论文部分内容阅读
人胎胸腺素(TH)是一种免疫增强剂,能促进和调节机体免疫功能,增强机体的抗病能力。我科从1992年4月至12月采用成都生物制品研究所提供的人胎胸腺素治疗肺癌病人50例,进行临床疗效和毒副作用观察。现将其临床应用结果报告如下:
Human fetal thymosin (TH) is an immunopotentiator that promotes and regulates immune function and enhances the body’s resistance to disease. In our department, from April to December 1992, 50 cases of lung cancer patients treated with human fetal thymosin provided by Chengdu Institute of Biological Products were observed for clinical efficacy and side effects. The clinical application results are now reported as follows: